1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AMGEN INC.
AMGEN Inc.
XNAS: AMGN
Turnaround Potential
Download real time
414.877.43(1.82%)
44.05% Gain from 52W Low
2.6M
XNAS Volume

XNAS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Amgen quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Amgen share price target, revenues, EPS, net income and more

Amgen quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Amgen Jun-2026 Quarterly Revenue is $10,054 Million which is growth of 9.5% YoY.

  • POSITIVE

    Quarterly Net Profit Amgen Jun-2026 Quarterly Net Profit is $2,375 Million which is growth of 65.9% YoY.

AMGEN Inc., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
10,0548,6189,8669,5579,1798,1499,0868,5038,3887,4478,1966,9036,986
Cost Of Rev.
2,8112,7442,9763,0823,0112,9683,1123,3103,2363,2003,1121,8061,813
Gross Profit
7,2435,8746,8906,4756,1685,1815,9745,1935,1524,2475,0845,0975,173
⌄
3,7293,2084,1703,9493,5124,0033,6633,1463,2433,2563,8133,0762,489
Operating Profit
3,5142,6662,7202,5262,6561,1782,3112,0471,9099911,2712,0212,684
⌄
-673-657-653-685-694-723-747-776-808-824-821-759-752
Profit Before Tax
2,7682,0841,5143,9211,5681,9737823,101794-688521,9471,614
Tax
393265181705136243155271484585217235
⌄
2,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,379
Diluted NI Avail to Com Stockholders Ann.
2,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,379
Basic EPS
4.43.42.562.73.21.25.31.4-0.21.43.22.6
Diluted EPS After ExtraOrdinary
6.35.25.35.664.95.35.6544.755
Number Of Shares End
540540538538538538537537537536535535535
Net Income Continuing Discontinued Operations
2,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,379
Normalized Income
3,4232,7992,8753,0553,2582,6492,8793,0242,6912,1402,5432,6672,683
Interest Income
-------------
Interest
673657653685694723747776808824821759752
Net Interest Income
-673-657-653-685-694-723-747-776-808-824-821-759-752
EBIT
3,4412,7412,1674,6062,2622,6961,5293,8771,6027561,6732,7062,366
EBITDA
4,5533,8573,2995,9133,6034,0832,9265,2733,0022,1553,0533,6013,262
Reconciled Cost Of Rev.
2,8112,7442,9763,0823,0112,9683,1123,3103,2363,2003,1121,8061,813
Reconciled Depr.
1,1121,1161,1321,3071,3411,3871,3971,3961,4001,3991,380895896
Profit From Continuing Operations
2,3751,8191,3333,2161,4321,7306272,830746-1137671,7301,379
Normalized EBITDA
4,5533,8573,2995,9133,6034,0832,9265,2733,0022,1553,0533,6013,262
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Amgen competitor comparison and performance snapshot within industry

Amgen annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Annual Revenue Amgen Dec-2025 Annual Revenue is $36,751 Million which is growth of 10.0% YoY.

  • POSITIVE

    Annual Net Profit Amgen Dec-2025 Annual Net Profit is $7,711 Million which is growth of 88.5% YoY.

AMGEN Inc., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
11.8%
7.6%
 36,75133,42428,19026,32325,97925,42423,36223,74722,84922,99121,662
Cost Of Rev. Ann.
23.4%
14.3%
11,61312,03712,8588,4516,4066,4546,1594,3564,1014,0694,1624,227
Gross Profit Ann.
7.5%
5.1%
26,48224,71420,56619,73919,91719,52519,26519,00619,64618,78018,82917,435
Operating Exp. Ann.
14.7%
9.1%
15,05615,63413,30811,84210,35111,88610,1269,3329,3838,8079,0358,965
Operating Profit Ann.
-1.7%
-0.1%
11,4269,0807,2587,8979,5667,6399,1399,67410,2639,9739,7948,470
⌄
-
-
-2,668-2,755-3,155-2,875-1,406-1,197-1,006-536-718-376-631-492
Other Exp. Ann.
-
-
 2,6515062,833-814259------
PBT Ann.
6.9%
2%
10,2878,9764,6097,8557,3466,7018,1339,1389,5459,5979,1637,978
Tax Ann.
16.8%
7.8%
1,5441,2655191,1387948088691,2961,1517,6181,4411,039
⌄
5.6%
1.2%
8,7437,7114,0906,7176,5525,8937,2647,8428,3941,9797,7226,939
Diluted NI Avail to Com Stockholders Ann.
5.6%
1.2%
8,7437,7114,0906,7176,5525,8937,2647,8428,3941,9797,7226,939
EPS Ann.
5.4%
2.9%
 14.37.612.612.210.312.41312.72.710.39.2
Diluted EPS Ann.
5.5%
2.9%
 14.27.612.512.110.312.312.912.62.710.29.1
Number Of Shares End
0.2%
-1.5%
 538537535535564580593637725736752
Total Exp. Ann.
18.2%
11.2%
 27,67126,16620,29316,75718,34016,28513,68813,48412,87613,19713,192
Net Income Continuing Discontinued Operations Ann.
5.6%
1.2%
8,7437,7114,0906,7176,5525,8937,2647,8428,3941,9797,7226,939
Normalized Income Ann.
7.3%
3.9%
12,15211,83710,73410,0349,5709,7979,7959,0289,5739,2468,7857,954
Interest Income Ann.
-
-
 -----256753674928629603
Interest Ann.
25.1%
16.9%
2,6682,7553,1552,8751,4061,1971,2621,2891,3921,3041,2601,095
EBITDA Ann.
11.8%
5.7%
17,62216,79413,25814,61512,01311,14212,74011,88012,20911,92811,89910,578
Reconciled Cost Of Rev. Ann.
23.4%
14.3%
11,61312,03712,8588,4516,4066,4546,1594,3564,1014,0694,1624,227
Reconciled Depr. Ann.
14.8%
7.5%
4,6675,1675,5924,0713,4173,3983,6012,2061,9461,9552,1052,108
Profit From Continuing Operations Ann.
5.6%
1.2%
8,7437,7114,0906,7176,5525,8937,2647,8428,3941,9797,7226,939
Normalized EBITDA Ann.
11.6%
5.4%
17,62216,89813,35614,80112,16911,29612,99612,63312,88312,85612,52811,181
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
10%
2Y CAGR
14.2%
3Y CAGR
11.8%
5Y CAGR
7.6%
7Y CAGR
6.4%
10Y CAGR
5.4%
Total Revenue Annual growth is stable compared to historical averages.
Net Profit Ann.
1Y CHG
88.5%
2Y CAGR
7.1%
3Y CAGR
5.6%
5Y CAGR
1.2%
7Y CAGR
-1.2%
10Y CAGR
1.1%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
17.5%
2Y CAGR
14.9%
3Y CAGR
14.7%
5Y CAGR
9.1%
7Y CAGR
7.6%
10Y CAGR
5.7%
Operating Expenses Annual Cr growth is higher than historical averages.

Amgen balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Total Shareholders Fund Amgen Dec-2025 Total Shareholders Fund is $8,658 Million which is growth of 47.3% YoY.

  • NEGATIVE

    Total Assets Amgen Dec-2025 Total Assets is $90,586 Million which is growth of -1.4% YoY.

AMGEN Inc., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
11.6%
7.6%
90,58691,83997,15465,12161,16562,94859,70766,41679,95477,62671,576
⌄
10.1%
8.9%
81,92885,96290,92261,46054,46553,53950,03453,91654,71347,75143,493
⌄
33.2%
-1.6%
8,6585,8776,2323,6616,7009,4099,67312,50025,24129,87528,083
Total Capitalization Ann.
12.7%
6.8%
58,66362,42669,40241,01539,92242,30436,62342,01059,43160,06857,389
Tangible Assets Ann.
-
-
-32,298-40,459-45,038-27,948-23,372-21,867-24,443-9,6421,8714,8451,655
Working Capital Ann.
-18.1%
-17.8%
3,5685,93111,9406,4997,2019,4915,60524,13040,45634,80629,851
Invested Capital Ann.
14.1%
8.3%
63,26265,97670,84542,60640,00942,39539,57646,42960,58364,47159,639
Tangible Book Value Ann.
-
-
-32,298-40,459-45,038-27,948-23,372-21,867-24,443-9,6421,8714,8451,655
Borrowings Ann.
11.9%
10.6%
54,60460,09964,61338,94533,30932,98629,90333,92935,34234,59631,556
Net Debt Ann.
13.2%
11.2%
45,47548,12653,66931,31625,32026,72023,86626,98431,54231,35527,412
Share Issued Ann.
0.3%
-1.4%
538.8537535.4534558.3578.3591.4629.6722.2738754
Number Of Shares End
0.2%
-1.5%
538537535535564580593637725736752
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-1.4%
2Y CAGR
-3.4%
3Y CAGR
11.6%
5Y CAGR
7.6%
7Y CAGR
4.5%
10Y CAGR
2.4%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
10.3%
2Y CAGR
17.7%
3Y CAGR
17.6%
5Y CAGR
16.9%
7Y CAGR
9.5%
10Y CAGR
11.4%
Total Current Liabilities Annual Cr growth is stable compared to historical averages.
Total ShareHolders Funds Ann.
1Y CHG
47.3%
2Y CAGR
17.9%
3Y CAGR
33.2%
5Y CAGR
-1.6%
7Y CAGR
-5.1%
10Y CAGR
-11.1%
Total ShareHolders Funds Annual growth is higher than historical averages.

Amgen ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Book Value Per Share Amgen Book Value Per Share is $22 which is growth of 56.7% YoY.

  • NEUTRAL

    ROE Amgen ROE is 0% which is growth of 0% YoY.

AMGEN Inc., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
-4.33%8.28%10.38%9.50%11.84%12.44%11.47%2.51%10.35%9.87%
ROE Ann. %
-
-
-67.55%135.79%126.47%73.16%76.13%70.73%44.48%7.18%26.65%25.77%
ROIC %
-
-
-1.82.24.75.13.94.44.4-6.63.23.2
OPM Ann. %
-12.1%
-7.2%
24.71%21.71%28.01%36.34%29.40%35.95%41.41%43.22%43.65%42.60%39.10%
Inventory Turnover Ratio Ann.
-
-
-1.61.21.41.61.71.31.41.51.61.7
Asset Turnover Ann. %
-
-
-0.40.40.40.40.40.40.30.30.30.3
Working Capital Turnover Ann.
35.9%
30.7%
10.35.62.44.13.62.74.210.60.70.7
Quick Ratio Ann.
-
-
-0.8111.11.312.453.74
Current Ratio Ann.
-
-
-1.31.71.41.61.81.42.85.54.14.4
Interest Coverage Ratio Ann.
-
-
-2.53.76.26.67.48.17.98.48.38.3
LT Debt To Equity Ann.
-
-
-9.610.110.253.52.82.41.411
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Amgen cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Cash From Operating Activity Amgen Dec-2025 Cash From Operating Activity is $9,958 Million which is growth of -13.3% YoY.

  • NEGATIVE

    Net Cash Flow Amgen Dec-2025 Net Cash Flow is $-2,844 Million which is growth of -376.4% YoY.

AMGEN Inc., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
0.8%
-1%
9,95811,4908,4719,7219,26110,4979,15011,29611,17710,3549,077
⌄
-
-
-1,943-1,046-26,204-6,044733-5,4015,70914,339-4,024-8,658-5,547
⌄
-
-
-10,859-9,41521,048-4,037-8,271-4,867-15,767-22,490-6,594-2,599-3,117
Cash Plus Cash Eqv. End Of Year Ann.
6.2%
7.8%
9,12911,97310,9447,6297,9896,2666,0376,9453,8003,2414,144
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-
-2,8441,0293,315-3601,723229-9083,145559-903413
Cash Plus Cash Eqv. Begin Of Year Ann.
14.4%
14.7%
11,97310,9447,6297,9896,2666,0376,9453,8003,2414,1443,731
Income Tax Paid Supplemental Data Ann.
-
-
-----------
Interest Paid Supplemental Data Ann.
-
-
-----------
Capex Ann.
-
-
-1,858-1,096-1,112-936-880-608-618-738-664-837-649
Issuance Of Capital Stock Ann.
-
-
-----------
Issuance Of Debt Ann.
-
-
27,7776,9194,9458,9144,4767,3183,465
Repayment Of Debt Ann.
-
-
-5,000-3,600-1,454-4,150-6,450-4,514-1,121-4,405-3,725-2,400
Repurchase Of Capital Stock Ann.
-
-
-200-6,360-4,975-3,486-7,702-17,794-3,160-2,965-1,867
Free Cash Flow Ann.
-2.7%
-3.9%
8,10010,3947,3598,7858,3819,8898,53210,55810,5139,5178,428
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-13.3%
2Y CAGR
8.4%
3Y CAGR
0.8%
5Y CAGR
-1%
7Y CAGR
-1.8%
10Y CAGR
0.9%
Cash from Operating Activity Annual is falling faster than historical averages.
×